Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hoelzer

Showing results (271-280 of 415) with videos related to

Pageof 42
Sort By:
Annals of Hematology|December 3, 2003
A randomized multicenter open label phase II study to determine the safety and efficacy of induction therapy with imatinib (Glivec, formerly STI571) in comparison with standard induction chemotherapy in elderly (>55 years) patients with Philadelphia chromosome-positive (Ph+/BCR-ABL+) acute lymphoblastic leukemia (ALL) (CSTI571ADE 10)B Wassmann, N Gökbuget, U J Scheuring, et al.
International Journal of Hematology|May 25, 2001
Murine M2-10B4 and SL/SL cell lines differentially affect the balance between CD34+ cell expansion and maturationS Koschmieder, G Bug, B Schröder, et al.
Annals of Hematology|March 1, 1993
Analysis of lymphocyte subsets in patients with aplastic anemia before and during immunosuppressive therapyU Mentzel, H Vogt, R Rossol, et al.
European Cytokine Network|March 8, 2000
Interleukin-18 stimulates HIV-1 replication in a T-cell lineS A Klein, C Klebba, D Kauschat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
Fludarabine and epirubicin in the treatment of chronic lymphocytic leukaemia: a German multicenter phase II studyM J Rummel, G Käfer, M Pfreundschuh, et al.
Blood|April 15, 1994
Development of the glycosylphosphatitylinositol-anchoring defect characteristic for paroxysmal nocturnal hemoglobinuria in patients with aplastic anemiaJ Schubert, H G Vogt, M Zielinska-Skowronek, et al.
Bone Marrow Transplantation|September 1, 1996
Residual leukemia and immunomagnetic bead purging in patients with BCR-ABL-positive acute lymphoblastic leukemiaJ Atta, H Martin, J Bruecher, et al.
British Journal of Haematology|February 15, 2002
A new approach to evaluating intestinal acute graft-versus-host disease by transabdominal sonography and colour Doppler imagingS A Klein, H Martin, D Schreiber-Dietrich, et al.
British Journal of Haematology|February 1, 1997
Clonal expansion of Vgamma3/Vdelta3-expressing gammadelta T cells in an HIV-1/2-negative patient with CD4 T-cell deficiencyD Kabelitz, T Hinz, T Dobmeyer, et al.
Leukemia & Lymphoma|December 1, 1996
Peripheral T-cell lymphomas respond well to vincristine, adriamycin, cyclophosphamide, prednisone and etoposide (VACPE) and have a similar outcome as high-grade B-cell lymphomasT Karakas, L Bergmann, H J Stutte, et al.
Pageof 42

Showing results (271-280 of 415) with videos related to

Sort By:
Pageof 42
Annals of Hematology|December 3, 2003
A randomized multicenter open label phase II study to determine the safety and efficacy of induction therapy with imatinib (Glivec, formerly STI571) in comparison with standard induction chemotherapy in elderly (>55 years) patients with Philadelphia chromosome-positive (Ph+/BCR-ABL+) acute lymphoblastic leukemia (ALL) (CSTI571ADE 10)B Wassmann, N Gökbuget, U J Scheuring, et al.
International Journal of Hematology|May 25, 2001
Murine M2-10B4 and SL/SL cell lines differentially affect the balance between CD34+ cell expansion and maturationS Koschmieder, G Bug, B Schröder, et al.
Annals of Hematology|March 1, 1993
Analysis of lymphocyte subsets in patients with aplastic anemia before and during immunosuppressive therapyU Mentzel, H Vogt, R Rossol, et al.
European Cytokine Network|March 8, 2000
Interleukin-18 stimulates HIV-1 replication in a T-cell lineS A Klein, C Klebba, D Kauschat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 1999
Fludarabine and epirubicin in the treatment of chronic lymphocytic leukaemia: a German multicenter phase II studyM J Rummel, G Käfer, M Pfreundschuh, et al.
Blood|April 15, 1994
Development of the glycosylphosphatitylinositol-anchoring defect characteristic for paroxysmal nocturnal hemoglobinuria in patients with aplastic anemiaJ Schubert, H G Vogt, M Zielinska-Skowronek, et al.
Bone Marrow Transplantation|September 1, 1996
Residual leukemia and immunomagnetic bead purging in patients with BCR-ABL-positive acute lymphoblastic leukemiaJ Atta, H Martin, J Bruecher, et al.
British Journal of Haematology|February 15, 2002
A new approach to evaluating intestinal acute graft-versus-host disease by transabdominal sonography and colour Doppler imagingS A Klein, H Martin, D Schreiber-Dietrich, et al.
British Journal of Haematology|February 1, 1997
Clonal expansion of Vgamma3/Vdelta3-expressing gammadelta T cells in an HIV-1/2-negative patient with CD4 T-cell deficiencyD Kabelitz, T Hinz, T Dobmeyer, et al.
Leukemia & Lymphoma|December 1, 1996
Peripheral T-cell lymphomas respond well to vincristine, adriamycin, cyclophosphamide, prednisone and etoposide (VACPE) and have a similar outcome as high-grade B-cell lymphomasT Karakas, L Bergmann, H J Stutte, et al.
Pageof 42